AbbVie Inc.
ABBV · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $4,286 | $4,820 | $11,845 | $11,549 |
| Dep. & Amort. | $8,386 | $8,698 | $8,467 | $8,521 |
| Deferred Tax | -$1,449 | -$2,889 | -$1,931 | -$898 |
| Stock-Based Comp. | $911 | $747 | $671 | $692 |
| Change in WC | -$2,782 | $2,813 | -$258 | -$1,322 |
| Other Non-Cash | $9,454 | $8,650 | $6,149 | $4,235 |
| Operating Cash Flow | $18,806 | $22,839 | $24,943 | $22,777 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$974 | -$777 | -$695 | -$787 |
| Net Acquisitions | -$17,493 | -$1,223 | -$794 | -$1,902 |
| Inv. Purchases | -$73 | -$77 | -$1,438 | -$119 |
| Inv. Sales/Matur. | $555 | $55 | $1,530 | $98 |
| Other Inv. Act. | -$2,835 | $13 | $774 | $366 |
| Investing Cash Flow | -$20,820 | -$2,009 | -$623 | -$2,344 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $7,350 | -$4,149 | -$12,433 | -$8,414 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$1,708 | -$1,972 | -$1,487 | -$934 |
| Dividends Paid | -$11,025 | -$10,539 | -$10,043 | -$9,261 |
| Other Fin. Act. | $172 | -$562 | -$840 | -$430 |
| Financing Cash Flow | -$5,211 | -$17,222 | -$24,803 | -$19,039 |
| Forex Effect | -$65 | $5 | -$62 | -$97 |
| Net Chg. in Cash | -$7,290 | $3,613 | -$545 | $1,297 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $12,814 | $9,201 | $9,746 | $8,449 |
| End Cash | $5,524 | $12,814 | $9,201 | $9,746 |
| Free Cash Flow | $17,832 | $22,062 | $24,248 | $21,990 |